Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Utah House rejects second‑substitute to study care of transgender minors after heated debate on puberty blockers
Summary
Lawmakers on the Utah House floor narrowly considered a second substitute for House Bill 449, which would have authorized an expedited Department of Health study of diagnosis, treatment and care for transgender minors; the measure failed 17–55 amid concerns about puberty‑blocking drug Lupron and community controversy.
Representative Karen Dahl, sponsor of House Bill 449 (second substitute), told the House the measure was intended to expedite a literature review by a panel of unbiased researchers about the diagnosis, treatment and care of transgender minors and, if the Department of Health could use direct contracting, to return the study in a shorter timeframe.
Dahl acknowledged the bill had generated “a lot of concern and a lot of controversy” and said she had encountered resistance to earlier proposals…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
